Skip to main content
logo
HCW Biologics Inc. (HCWB)
NASDAQ: HCWB · Real-Time Price · USD
0.3800
-0.0010 (-0.26%)
Apr 22, 2026, 1:08 PM EDT - Market open

HCW Biologics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
3320446983
Market Cap Growth
-76.14%-83.47%-55.17%-35.50%-17.22%-
Enterprise Value
7.68.1428.8847.0243.0446.27
Last Close Price
0.380.9717.8449.2076.5992.80
PE Ratio
--0.09-0.58-1.76-4.56-3.36
PS Ratio
50.5460.577.7415.5910.22-
PB Ratio
0.451.19-2.933.291.841.62
P/TBV Ratio
0.290.74-2.563.281.830.85
P/FCF Ratio
--0.25-1.37-1.54-3.32-7.53
P/OCF Ratio
--0.25-1.40-1.97-6.61-7.56
EV/Sales Ratio
140.09150.1211.2516.556.40-
EV/EBITDA Ratio
--0.67-1.02-1.91-3.00-3.61
EV/EBIT Ratio
--0.62-0.98-1.83-2.85-3.46
EV/FCF Ratio
--0.61-1.99-1.64-2.08-4.20
Debt / Equity Ratio
2.462.46-2.020.470.170
Debt / EBITDA Ratio
-0.56-0.56-0.48-0.26-0.45-
Debt / FCF Ratio
-0.51-0.51-0.94-0.22-0.31-
Net Debt / Equity Ratio
1.761.76-1.330.20-0.68-0.72
Net Debt / EBITDA Ratio
-0.40-0.40-0.32-0.111.792.86
Net Debt / FCF Ratio
-0.36-0.36-0.62-0.091.243.33
Asset Turnover
0.000.000.090.080.130
Quick Ratio
0.090.090.180.5910.9915.87
Current Ratio
0.110.110.190.7311.5217.44
Return on Equity (ROE)
397.45%397.45%-897.37%-98.23%-33.63%-39.22%
Return on Assets (ROA)
-48.15%-48.08%-100.28%-68.29%-30.06%-38.80%
Return on Invested Capital (ROIC)
-249.65%-249.25%-319.85%-183.95%-114.80%-130.93%
Return on Capital Employed (ROCE)
-648.65%-647.60%-289.16%-80.85%-31.73%-40.76%
Earnings Yield
-813.59%-1095.20%-173.54%-56.91%-21.93%-29.74%
FCF Yield
-488.61%-407.71%-72.94%-64.81%-30.08%-13.28%
Buyback Yield / Dilution
-116.30%-116.30%-7.97%-0.30%-90.84%-296.07%
Total Shareholder Return
-116.30%-116.30%-7.97%-0.30%-90.84%-296.07%
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q